Trustiva Tablet (Emtricitabine/Tenofovir/Efavirenz)

Trustiva Tablets contain two active substances, Emtricitabine and Tenofovir disoproxil fumarate. These medications are a part of the standard combination therapy for HIV, known as antiretroviral therapy (ART). It is a combination drug regimen that is commonly used for the effective treatment of HIV-1 infection. When used correctly and consistently, Trustiva tablets have demonstrated high efficacy in HIV treatment and prevention

These should not be used in individuals with known hypersensitivity or severe allergic reactions to Emtricitabine, Tenofovir disoproxil fumarate, or any medication components. This medication is not recommended in individuals with severe renal impairment or end-stage renal disease who are not receiving hemodialysis

Trustiva Tablet is used to treat HIV-1 infection

Trustiva Tablet has therapeutic effects in treating HIV infection and pre-exposure prophylaxis (PrEP). They work by inhibiting HIV replication, reducing viral load, improving immune function, and slowing the progression of HIV disease. In individuals with HIV, these medications help control the virus, maintain a low viral load, and improve overall health outcomes

Inform your healthcare provider about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Trustiva Tablet, reducing effectiveness by causing undesirable side effects

• Store at a temperature between 20°C to 25°C (68°F to 77°F).
• Keep away from moisture, heat, and light.
• It should not be frozen.
• Keep it in its original packaging.
• Keep away from children and pets

To properly consume Trustiva Tablet, follow your healthcare provider's instructions regarding dosage, frequency, and duration. Take it with or without food, swallowing the tablets or capsules with water. Adhere to the prescribed dosing schedule; do not alter the dosage without consulting your healthcare provider